Recent research indicates that semaglutide, the active ingredient found in popular weight-loss and diabetes medications Ozempic and Wegovy, may offer benefits beyond metabolic health. A new study has found that the drug slowed biological aging markers in adults living with HIV.
A Potential Breakthrough in Longevity
This discovery marks the first clinical evidence suggesting that semaglutide can influence the biological aging process in humans. While the drugs are primarily known for managing blood sugar and inducing weight loss, researchers are now exploring their potential to mitigate age-related decline.
Further Research Required
Although the initial findings are described as encouraging, the scientific community remains cautious. Experts emphasize that larger, more comprehensive clinical trials are necessary before concluding that semaglutide can be prescribed as an anti-aging medication for the general population.
